This Article Full Text Full Text (PDF) All Versions of this Article: bjo.2007.124768v1 92/5/678    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Ferrer, C Articles by Alió, J L PubMed PubMed Citation Articles by Ferrer, C Articles by Alió, J L Topic Collections Related Article

Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis

¹ Department of Molecular Biology, VISSUM, Institute of Ophthalmology of Alicante, Alicante, Spain
² Division of Ophthalmology, Faculty of Medicine, University of Miguel Hernández, Alicante, Spain

Correspondence to:
Dr C Ferrer, VISSUM, Instituto Oftalmológico de Alicante, Avenida de Denia s/n, 03016 Alicante, Spain; cferrer{at}vissum.com

ABSTRACT
Aim: To evaluate the efficacy of intravitreal 1.5% levofloxacin versus combined treatment with vancomycin and ceftazidime in an experimental model of bacterial endophthalmitis.

Methods: The right eye of 75 New Zealand White rabbits was inoculated in the vitreous cavity with strains of Staphylococcus epidermidis, Staphylococcus aureus or Pseudomonas aeruginosa. The study evaluated treatment with 1.5% levofloxacin compared with 1% vancomycin plus 2.2% ceftazidime, and a control group. At 24 h after treatment, 100 µl vitreous and aqueous humor were harvested, and the number of colony-forming units (CFU) per ml was determined. The microbiological status of the vitreous and aqueous humor samples was tested at day 2, 3, 5 and 8. The Peyman classification was used to assess the severity of endophthalmitis.

Results: For the S epidermidis endophthalmitis model, levofloxacin treatment produced an approximately 3 log decrease in CFU/ml of vitreous relative to that in untreated eyes (p = 0.023), whereas vancomycin plus ceftazidime produced a 5 log reduction in CFU/ml (p = 0.023). However, in the S aureus model, levofloxacin treatment produced an approximately 4 log reduction in CFU/ml, whereas vancomycin plus ceftazidime produced an approximately 2 log reduction in CFU/ml relative to that of the control (p = 0.018 and p = 0.019, respectively). Treatment of P aeruginosa-infected rabbit eyes with levofloxacin produced a 5 log reduction in CFU/ml of vitreous, whereas vancomycin plus ceftazidime produced an approximately 3–4 log reduction in CFU/ml relative to that of the control (p = 0.001). However, there was no significant difference between levofloxacin and vancomycin plus ceftazidime on comparing the reduction of CFU/ml of vitreous for any of the bacterial strains studied.

Conclusions: Levofloxacin appears to be effective in treating experimental endophthalmitis in the rabbit model. Further studies, especially on the toxicity of intravitreal levofloxacin, are required before a clinical role for the drug in postoperative therapy can be determined.

Competing interests: VISSUM has received funds for research from Santen OY, Finland.

Related Article

At a glance

Harminder S Dua and Arun D Singh
Br. J. Ophthalmol. 2008 92: 585. [Extract] [Full Text] [PDF]